论文部分内容阅读
肺原性心脏病(简称肺心病)是以肺、心病变为主的全身性疾病,比较复杂,轻重不等,治疗又经常采取针对几个环节的综合性措施,故给判断药物疗效带来困难。与会代表经过反复讨论,归纳如下几方面意见,这个意见很不成熟,供各地参考、修改、补充。一、感染方面:判定有无感染及其程度应是综合性的。主要根据体温、痰的颜色及性状、肺部体征、周身中毒情况、血沉、白血球总分计数、血压及痰细菌培养和炎细胞数等。重度感染:指发热、白血球增多、脓性痰,痰炎细胞在30,000/毫升以上,肺部罗
Pulmonary heart disease (referred to as pulmonary heart disease) is a systemic disease mainly of lung and heart disease, more complex, severity range, treatment often take a comprehensive approach for several aspects, so to determine the efficacy of drugs brought difficult. After repeated discussions, delegates summarized the following opinions, which is a very immature idea for reference, revision and supplement. First, the infection: to determine whether the infection and its extent should be comprehensive. Mainly based on body temperature, sputum color and traits, signs of the lungs, systemic poisoning, erythrocyte sedimentation rate, total white blood cell count, blood pressure and sputum bacterial culture and inflammatory cell number. Severe infection: refers to fever, leukocytosis, purulent sputum, sputum cells in 30,000 / ml above, lung Luo